Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02640950 · ClinicalTrials.gov registry record · NA
An Open Label Trial of TMS Therapy for Bipolar Depression
A NA study, sponsored by Sheppard Pratt Health System.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT02640950 is a NA study that has completed, run by Sheppard Pratt Health System. The registered enrollment target is 31 participants.
The verdict
NCT02640950, a NA study, has completed, sponsored by Sheppard Pratt Health System.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
Transcranial Magnetic Stimulation (TMS) is an increasingly accepted neurostimulation- based treatment for major depressive disorder. While there is a growing anecdotal database supporting its use in bipolar depression the investigators propose to collect open label efficacy and safety data in a small population of patients with clinically verified bipolar disorder.
Interventions
- DEVICE NeuroStar TMS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2015-12 |
| Est. Completion | 2020-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02640950
The ClinicalTrials.gov registry entry for NCT02640950 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sheppard Pratt Health System, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which NeuroStar TMS is the first listed.
NCT02640950 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02640950 about?
NCT02640950 is a clinical study titled "An Open Label Trial of TMS Therapy for Bipolar Depression". Transcranial Magnetic Stimulation (TMS) is an increasingly accepted neurostimulation- based treatment for major depressive disorder. While there is a growing anecdotal database supporting its use in bipolar depression the investigators propose to collect open label efficacy and safety data in a smal...
What is the current status of trial NCT02640950?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2015-12. Estimated completion is 2020-07.
What interventions are being tested in trial NCT02640950?
The interventions under investigation include: NeuroStar TMS (DEVICE).
Who is sponsoring clinical trial NCT02640950?
This trial is sponsored by Sheppard Pratt Health System, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.